Connect with us

Hi, what are you looking for?

Capital Business
Capital Business
AstraZeneca raises earnings outlook as sales climb/AFP

World

AstraZeneca raises earnings outlook as sales climb

AstraZeneca raises earnings outlook as sales climb/AFP

AstraZeneca raises earnings outlook as sales climb/AFP

LONDON, July 31 – British Swedish drugmaker AstraZeneca, which fought off a takeover from Pfizer earlier this year, raised its 2014 earnings outlook on Thursday and posted rising second quarter sales.

Turnover gained four percent to $6.454 billion (4.819 billion euros) in the three months to June from a year earlier, aided by emerging markets and the United States, Astra said in a results statement.

The performance was also lifted by the inclusion of AstraZeneca’s former diabetes joint venture. The group bought out partner Bristol-Myers Squibb late last year for $4.1 billion.

In addition, sales were pushed higher by delays to the launch of generic versions of Astra’s best-selling heartburn pill Nexium by Indian drugmaker Ranbaxy.

AstraZeneca added it expected 2014 revenues to be in line with the prior year. That was an upgrade from previous guidance for low to mid single digit percentage decline.

Earnings per share (EPS) — a key measure of company performance — was expected to fall in low double digits this year. That marked an upgrade from the prior estimates for a percentage drop in the teens.

“We have made significant progress in the first half of the year, with visible momentum across our cardiovascular, diabetes and respiratory franchises as well as strong growth in the emerging markets,” said chief executive Pascal Soriot in the statement.

“This has driven revenue growth for the second consecutive quarter and achieved a 13 percent increase in core earnings per share in the quarter.

“The pace of execution of our strategy and the underlying performance of our teams give us confidence to raise 2014 guidance for the full year.”

On a downbeat note, Astra added that net profits, or earnings after taxation, dipped by 3.3 percent to $796 million in the reporting period, hit by ongoing investment in new drug development.

Advertisement. Scroll to continue reading.

The results were meanwhile published one day after AstraZeneca agreed to purchase a portfolio of respiratory drugs from Spanish pharmaceuticals firm Almirall for up to $2.1 billion.

“The business combination with Almirall will offer strategic long-term value, bringing together the two innovative portfolios to strengthen further our commitment to respiratory disease and contribute to our growth,” added Soriot on Thursday.

In late May, AstraZeneca fought off a $117 billion takeover bid from US giant Pfizer, amid worries over British jobs and research capability.

There were also accusations that the tie up was a cynical ploy by Pfizer to avoid paying tax on profits if they were sent to the United States. The group had also proposed to switch its tax base to Britain from the US.

Under British takeover rules, Pfizer must now wait six months before it can bid again for AstraZeneca.

Click to comment
Advertisement

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Headlines

NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...

Kenya

NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...

Coronavirus

NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...

Coronavirus

NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...